Skip to main content
. 2021 Nov 26;11:768035. doi: 10.3389/fonc.2021.768035

Figure 3.

Figure 3

Sensitivity analyses of pembrolizumab group versus placebo group. (A) Deterministic sensitivity analysis of two groups. (B) Probabilistic sensitivity analysis of two groups. ICER, $/QALY; ppeme, price of pemetrexed; pfsu, utility of PFS; rdis, discount rate; pdu, utility of PD; pnivo, price of nivolumab; ppem, price of pembrolizumab; checkm, cost of imaging examination and laboratory test per cycle; pladm, cost of medical service of chemotherapy per cycle; pdoce, price of docetaxel; pemdm, cost of medical service of pembrolizumab therapy per cycle; pcar, price of carboplatin; Willingness to pay, $/QALY; strategy I, pembrolizumab plus pemetrexed and platinum; strategy II, chemotherapy alone.